Muhammad Adnan et al. 2024. RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE STUDIES OF SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) AND DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS EMPAGLIFLOZIN AND LINAGLIPTIN IN PHARMACEUTICAL DOSAGE FORM. Journal of Population Therapeutics and Clinical Pharmacology. 31, 5 (May 2024), 1697–1709. DOI:https://doi.org/10.53555/jptcp.v31i5.6335.